ACHIEVE YOUR NEXT BREAKTHROUGH
using the world’s most powerful 3D in situ
multi-omic analysis technology
WHY STELLAROMICS
Empowering a brighter biomedical future
Welcome to the new world of in situ analysis. Now you can capture high resolution 3D multi-omic information from thick tissue samples, mapping gene expression patterns while preserving the spatial integrity and anatomical structure of the cells in the tissue being studied.
STELLAR TECHNOLOGY
Faster, richer discovery straight from the STARs
Stellaromics uses its proprietary and industry-leading STARmap (Spatially-resolved Transcript Amplicon Readout mapping) technology to optically extract multi-omic information from biological tissue so researchers can better understand tissue functions and dysfunctions, and which cells may be targeted by specific interventions.
INTRODUCING PLEXA
Powerful, fully annotated multi-omic maps at your fingertips
Discover how individual cells work and how multiple cell types relate to each other across imaging layers using the Stellaromics Plexa suite of devices, reagents, software, and services. Click here to inquire about accessing the STARmap technology through our upcoming services program.
ABOUT STELLAROMICS
Power. Precision. Innovation. Ingenuity.
Stellaromics was founded in 2022 by a team of world renowned scientists on a mission to move biomedical research forward faster. The Plexa suite of products was developed to extend their progress by empowering others to innovate alongside them.
Stellaromics in numbers
12 slices/run
Cell profiling of upto 12 tissue slices in one run
4000 genes
Imaging up to 4000 genes at once
20 nt
Targeting RNA regions/species as short as 20 nucleotides
1 million
Studying 1 million cells per experiment
200 um
Analyzing biological tissue up to 200 um thickness
100 nm
Achieving sub-cellular spatial resolution of <100 nm